Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-2876 | HAEGTFTSDVSSYLE CAS No.926018-57-7 | HAEGTFTSDVSSYLE/CAS No.926018-57-7 is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence. | price> |
| R-C-1177 | GS-7340(Tenofovir alafenamide ) CAS:379270-37-8 | Tenofovir Alafenamide(GS-7340)is a prodrug of tenofovir,which is a reverse transcriptase inhibitor,used to treat HIV and Hepatitis B. | price> |
| R-R-2877 | PA-8 CAS No.878437-15-1 | PA-8/CAS No.878437-15-1 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA-8 inhibits the phosphorylation of CREB induced by PACAP in PAC1-, but not VPAC1- or VPAC2-receptor. PA-8 also inhibits PACAP-induced cAMP elevation with an IC50 of 2 nM. | price> |
| R-C-1178 | GSK503 CAS:1346572-63-1 | GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Kiapp values of 3 to 27 nM. | price> |
| R-R-2878 | PACAP (6-38), human, ovine, rat TFA | PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively. | price> |
| R-C-1179 | CGI-1746 CAS:910232-84-7 | CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. | price> |
| R-R-2879 | PAC1R antagonist 1 CAS No.2305204-24-2 | PAC1R antagonist 1 (compound 3d)/CAS No.2305204-24-2 is a potent and orally active antagonist of PAC1 receptor. PAC1R antagonist 1 can inhibit pituitary adenylate cyclase-activating polypeptide (PACAP)- and nerve injury-induced allodynia. | price> |
| R-C-1180 | Endoxifen CAS:112093-28-4 | Endoxifen is a secondary metabolite of tamoxifen.It is a primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer. | price> |
| R-R-2880 | PACAP (1-27), human, ovine, rat TFA | PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is the N-terminal fragment of PACAP-38, and is a potent PACAP receptor antagonist with IC50s of 3 nM, 2 nM and 5 nM for rat PAC1, rat VPAC1 and human VPAC2, respectively. | price> |
| R-C-1181 | D-Luciferin CAS :2591-17-5 | D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP,used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications. | price> |
| R-R-2881 | PACAP (1-38), amide, Biotin-labeled | PACAP (1-38), amide, Biotin-labeled is a biological active peptide. (Biotin-labeled HY-P0221) | price> |
| R-C-1182 | NS6180 | NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50=9nM) prevents T-cell activation and inflammation. | price> |
| R-R-2882 | PA-9 CAS No.1436004-46-4 | PA-9/CAS No.1436004-46-4 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain. | price> |
| R-C-1183 | Loxiglumide CAS:107097-80-3 | Loxiglumide is a potent,orally active,and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans.Loxiglumide inhibits pancreatic secretion of digestive enzymes,and also blocks CCK-induced gastric secretions and emptying.Intravenous administration of loxiglumide antagonized the CCK-induced reduction of gastric emptying in rats,acceleration of intestinal transport in mice,increase in ileal motility in rabbits, gallbladder contraction in guinea pigs and acceleration of gallbladder emptying in mice. | price> |
| R-R-2883 | (Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) CAS No.213779-11-4 | (Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat)/CAS No.213779-11-4 is a peptide and can be used as a parathyroid hormone (PTH) receptor ligand. | price> |
| R-C-1184 | BD1047.2HBr CAS 138356-21-5 | BD-1047 hydrobromide,a selective functional antagonist of sigma receptors,has antipsychotic activity in animal models predictive of efficacy in schizophrenia. | price> |
| R-R-2884 | Human PTHrP-(1-36) CAS No.172867-62-8 | Human PTHrP-(1-36)/CAS No.172867-62-8 is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism. | price> |
| R-C-1185 | Evacetrapib (LY2484595) CAS No. 1186486-62-3 | Evacetrapib is a potent and selective of CETP inhibitor,which inhibits human recombinant CETP protein(IC50 5.5 nM)and CETP activity in human plasma(IC50 36 nM)in vitro. | price> |
| R-R-2885 | Secretin (33-59), rat TFA | Secretin (33-59), rat (TFA) is a 27-aa peptide, which acts on secretin receptor, and enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas. | price> |
| R-C-1186 | TAE226 (NVP-TAE226) CAS:761437-28-9 | NVP-TAE 226(TAE226)is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM,respectively.NVP-TAE 226(TAE226) also effectively inhibits Pyk2 and insulin receptor(InsR)with IC50s of 3.5 nM and 44 nM,respectively. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


